Home/Pipeline/Islets-Immune Model

Islets-Immune Model

Immune rejection of islet transplants

Pre-clinicalActive

Key Facts

Indication
Immune rejection of islet transplants
Phase
Pre-clinical
Status
Active
Company

About Biopico Systems

Biopico Systems Inc. is a leader in developing interacting multiple organ systems, or microphysiological systems (MPS), aiming to revolutionize in vitro biomedical research. Its flagship OrganRX™ system is described as the world's first unidirectional gravity-driven flow multiorgan system in a multiwell plate format, enabling the study of cross-organ communication, systemic toxicity, and disease pathology. The company targets the critical need for more predictive preclinical models in drug development, particularly for complex biologics, by offering a platform that balances operational simplicity with physiological complexity. Biopico engages with partners through custom model development, compound profiling, and drug development collaborations.

View full company profile